Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) released a Letter to
Shareholders today that was filed as an 8k with the U.S. Securities and
Exchange Commission.
A copy of the letter can be found at the following link, http://mhtx.com/news-and-media/press-releases/letter-to-shareholders/
About Manhattan Scientifics, Inc.
Manhattan Scientifics Inc. (www.mhtx.com)
is located in New Mexico, New York and Montreal. It is focused on
technology transfer and commercialization of transformative technologies
in the nano medicine space. The company is presently developing
commercial medical prosthetics applications for its ultra-fine grain
metals and plans to commercialize the cancer research work and nano
medical applications developed by Senior Scientific LLC, a unit of the
Company.
Forward-looking statement
This press release contains forward-looking statements, which are
subject to a number of risks, assumptions and uncertainties that could
cause the Company's actual results to differ materially from those
projected in such forward-looking statements. Management at Manhattan
Scientifics believes that purchase of its shares should be considered to
be at the high end of the risk spectrum. Forward-looking statements
speak only as of the date made and are not guarantees of future
performance. We undertake no obligation to publicly update or revise any
forward-looking statements.
Copyright Business Wire 2015